Cell density-dependent expression of EDG family receptors and mesangial cell proliferation: Role in lysophosphatidic acid-mediated cell growth

American Journal of Physiology - Renal Physiology

Volumn 287, Issue 6 56-6, 2004, Pages

  Xing, Yiding ^b   Ganji, Shobha H ^b   Noh, Jung W ^b   Kamanna, Vaijinath S ^a  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

Glomerular disease; Lysophosphatidic acid receptors; Lysophospholipids; Renal disease

Indexed keywords

LYSOPHOSPHATIDIC ACID;

ARTICLE; CELL DENSITY; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; COMPARATIVE STUDY; DNA SYNTHESIS; ENDOTHELIAL DIFFERENTIATION GENE; GENE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL; RECEPTOR GENE;

EID: 8644229385     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00342.2003     Document Type: Article

References (47)

1. An S, Bleu T, Hallmark OG, and Goetzl EJ. Characterization of a novel subtype of human G-protein-coupled receptor for lysophosphatidic acid. J Biol Chem 273: 7906-7910, 1998.
2. Bandoh K, Aoki J, Hsono H, Kobayashi S, Kobayashi T, Murakami K, Tsujimoto M, Aria H, and Inoue K. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem 274: 27776-27785, 1999.
3. Batt DB and Roberts TM. Cell density modulates protein-tyrosine phosphorylation. J Biol Chem 273: 3408-3414, 1998.
4. Cameron JS. Platelets and glomerular disease. Annu Rev Med 35: 174-190, 1984.
5. Campbell JH, Kocher O, Skalli O, Gabbiani G, and Campbell GR. Cytodifferentiation and expression of α-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells. Correlation with cell density and proliferative state. Arteriosclerosis 9: 633-643, 1989.
6. Eichholtz T, Jalink K, Fahrenfort I, and Moolenaar WH. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J 291: 677-680, 1993.
7. Fiaschi T, Chiarugi P, Buricchi F, Giannoni E, Taddei ML, Talini D, Cozzi G, Zecchi-Orlandini S, and Raugei G. Low molecular weight protein-tyrosine phosphatase is involved in growth inhibition during cell differentiation. J Biol Chem 276: 49156-49163, 2001.
8. Fisher DJ, Nusser N, Virag T, Yokoyama K, Wang D, Baker DL, Bautista D, Parrill AL, and Tigyi G. Short chain phosphatides are subtype selective antagonists of LPA receptors. Mol Pharmacol 60: 776-784, 2001.
9. Fourcade O, Simon MF, Viode C, Rugan N, Leballe F, Ragab A, Fourne B, Sarda L, and Chap H. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid from membrane microvesicles shed from activated cells. Cell 80: 919-927, 1995.
10. Fukushima N and Chun J. The LPA receptors. Prostaglandins 64: 21-32, 2001.
11. Fukushima N, Ishii I, Contos JA, Weiner JA, and Chun J. Lysophospholipid receptors. Annu Rev Pharmacol Toxicol 41: 507-534, 2001.
12. Gaits F, Salles JP, and Chap H. Dual effect of lysophosphatidic acid on proliferation of glomerular mesangial cells. Kidney Int 51: 1022-1027, 1997.
13. Goodman LV and Majack RA. Vascular smooth muscle cells express distinct transforming growth factor-β receptor phenotypes as a function of cell density in culture. J Biol Chem 264: 5241-5244, 1989.
14. Hecht JH, Weiner JA, Post SR, and Chun J. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J Cell Biol 135: 1071-1083, 1996.
15. Heise CE, Santos WL, Schreihofer AM, Heasley BH, Mukhin YV, Macdonald TL, and Lynch KR. Activity of 2-substituted LPA analogs at LPA receptors: discovery of a LPA1/LPA3 receptor anagonist. Mol Pharmacol 60: 1173-1180, 2001.
16. Hla T and Maciag TJ. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G protein coupled receptors. J Biol Chem 265: 9308-9313, 1990.
17. Hooks SB, Santos WL, Im DS, Heise CE, Macdonald TL, and Lynch KR. Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is EDO-receptor independent. J Biol Chem 276: 4611-4621, 2001.
18. Im DS, Heise CE, Harding MA, George SR, O'Dowd BF, Theodorescu D, and Lynch KR. Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate. Mol Pharmacol 57: 753-759, 2000.
19. Inoue CN, Epstein M, Forster HG, Hotta O, Kondo Y, and Iinuma K. Lysophosphatidic acid and mesangial cells: implications for renal diseases. Clin Sci (Lond) 96: 431-436, 1999.
20. 2+ and contractility in cultured rat mesangial cells. Circ Res 77: 888-896, 1995.
21. Inoue CN, Ko YH, Guggino WB, Forster HG, and Epstein M. Lysophosphatidic acid and platelet-derived growth factor synergistically stimulate growth of cultured rat mesangial cells. Proc Soc Exp Biol Med 216: 370-379, 1997.
22. Inoue CN, Nagano I, Ichinohasama R, Asato N, Kondo Y, and Iinuma K. Bimodal effects of platelet-derived growth factor on rat mesangial cell proliferation and death, and the role of lysophosphatidic acid in cell survival. Clin Sci (Lond) 101: 11-19, 2001.
23. Ishi I, Contos JJ, Fukushima N, and Chun J. Functional comparisions of the lysophosphatidic acid receptors, LPA1/V2G-1/EDG-2, LPA2/ EDG-4, and LPA3/EDG-7 in neuronal cell lines using a retrovirus expression system. Mol Pharmacol 58: 895-902, 2000.
24. Ishimura E, Sterzel RB, Budde K, and Kashgarian M. Formation of extracellular matrix by cultured rat mesangial cells. Am J Pathol 134: 843-855, 1989.
25. 2+ induced by arterial natriuretic hormone, S-nitroso-N-acetylpenicillamine and 8-bromo cyclic GMP in cultured rat mesangial cells. Biochem J 274: 323-328, 1991.
26. Lynch KR. Lysophospholipid receptor nomenclature. Biochim Biophys Acta 1582: 70-71, 2002.
27. Majors AK and Ehrhart L. Cell density and proliferation modulate collagen synthesis and procollagen mRNA levels in arterial smooth muscle cells. Exp Cell Res 200: 168-174, 1992.
28. Moolenaar WH. Lysophosphatidic acid signaling. Curr Opin Cell Biol 7: 203-210, 1995.
29. Moolenaar WH. Development of our current understanding of bioactive lysophospholipids. Ann NY Acad Sci 905: 1-10, 2000.
30. Moolenaar WH, Kranenburg O, Postma FR, and Zondag GC. Lysophosphatidic acid: G-protein signaling and cellular responses. Curr Opin Cell Biol 9: 168-173, 1997.
31. Pages C, Daviaud D, An S, Krief S, Lafontan M, Valet P, and Saulnier-Blache JS. Endothelial differentiation gene-2 receptor is involved in lysophosphatidic acid-dependent control of 3T3F442A preadipocyte proliferation and spreading. J Biol Chem 276: 11599-11605, 2001.
32. Pani G, Colavitti R, Bedogni B, Anzevino R, Borrello S, and Galeotti T. A redox signaling mechanism for density-dependent inhibition of cell growth. J Biol Chem 275: 38891-38899, 2000.
33. Pfeilschifter J, Schalkwijk C, Briner VA, and van den Bosch H. Cytokine stimulated secretion of group II phospholipase A2 by rat mesangial cells. J Clin Invest 92: 2516-2523, 1993.
34. Rosner H, Greis C, and Rodemann HP. Density-dependent expression of ganglioside GM3 by human skin fibroblasts in an all-or-none fashion, as a possible modulator of cell growth in vitro. Exp Cell Res 190: 161-169, 1990.
35. Sasagawa T, Suzuki K, Shiota T, Konda T, and Okita M. The significance of plasma lysophospholipids in patients with renal failure on hemodialysis. J Nutr Sci Vitaminol (Tokyo) 44: 809-818, 1998.
36. Sugiura T, Wada A, Itoh T, Tojo H, Okamoto M, Imai E, Kamada T, and Ueda N. Group II phospholipase A2 activates mitogen-activated protein kinase in cultured rat mesangial cells. FEBS Lett 370: 141-145, 1995.
37. Thumser AE, Voysey JE, and Wilton DC. The binding of lysophospholipids to rat liver fatty acid-binding protein and albumin. Biochem J 301: 801-806, 1994.
38. Tigyi G. Physiological responses to lysophosphatidic acid and related glycero-phospholipids. Prostaglandins 64: 47-62, 2001.
39. Tigyi G and Miledi R. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells. J Biol Chem 267: 21360-21367, 1992.
40. Tokumura A, Harada K, Fukuzawa K, and Tsukatani H. Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma. Biochim Biophys Acta 875: 31-38, 1986.
41. Tokumura A, Yamano S, Aono T, and Fukuzawa K. Lysophosphatidic acids produced by lysophospholipase D in mammalian serum and body fluid. Ann NY Acad Sci 905: 347-350, 2000.
42. Van Corven EJ, Groenink A, Jalink K, Eichholtz T, and Moolenaar WH. Lysophosphadate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell 59: 45-54, 1989.
43. Wada A, Sugiura T, Arai M, Tojio H, Okamoto M, Fujiwara Y, Ueda N, and Kamada T. Group II phospholipase AII promotes mesangial cell proliferation via lysophospholipids. J Am Soc Nephrol 5: 704A, 1995.
44. Wada A, Tojo H, Sugiura T, Fujiwara Y, Kamada T, Ueda N, and Okamoto M. Group II phospholipase A2 as an autocrine growth factor mediating interleukin-1 action on mesangial cells. Biochim Biophys Acta 1345: 99-108, 1997.
45. Wolthuis A, Boes A, and Grond J. Cell density modulates growth, extracellular matrix, and protein synthesis of cultured rat mesangial cells. Am J Pathol 143: 1209-1219, 1993.
46. 2+ control lysophosphatidate signaling through EDG-2 receptor. J Biol Chem 275: 27520-27530, 2000.
47. Yang AH, Ishii I, and Chun J. In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice. Biochim Biophys Acta 1582: 197-203, 2002.